March 19, 2020 Bio/Pharma/CRO Environ, Ag./Food & Bev Lab Top-10 PR/Corporate

Danaher Receives Clearance From U.S. Federal Trade Commission For The Acquisition Of The Biopharma Business Of General Electric Life Sciences

Danaher Receives Clearance From U.S. Federal Trade Commission For The Acquisition Of The Biopharma Business Of General Electric Life Sciences WASHINGTON, March 19, 2020 /PRNewswire/ — Danaher Corporation (NYSE: DHR) (“Danaher”) announced today that the U.S. Federal Trade Commission (the “FTC”) has accepted the proposed consent order in connection with Danaher’s definitive agreement with General... Read more

March 13, 2020 PR/Corporate

QIAGEN gains BARDA funding for approval process of QIAstat-Dx test kit for SARS-CoV-2 coronavirus 

Hilden, Germany, and Germantown, Maryland, March 13, 2020 – QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced it will develop a new QIAstat-Dx test kit to differentiate the novel SARS-CoV-2 coronavirus from 21 other serious respiratory infections and will receive advanced development support from the U.S. Department of Health and Human Services’ Office of... Read more

March 13, 2020 Acad, Gov/Utilities PR/Corporate

Roche’s cobas SARS-CoV-2 Test to detect novel coronavirus receives FDA Emergency Use Authorization and is available in markets accepting the CE mark

First commercial test for SARS-CoV-2 will enable expedited coronavirus testing to meet urgent medical needs Testing on widely available, high-volume cobas 6800/8800 will significantly increase available testing capacity Roche expedites test development to support urgent need for patient testing during pandemic outbreak to avoid a further spread of the virus at an early stage of... Read more

March 11, 2020 Acad, Gov/Utilities Bio/Pharma/CRO PR/Corporate

Roche receives FDA approval for CINtec PLUS Cytology test to aid clinicians in improving cervical cancer prevention

Next-generation cytology test provides additional information for HPV-positive women who may have cervical pre-cancer More sensitive than Pap cytology testing when used as triage test for HPV-positive screening results, helping to improve the detection of cervical pre-cancer The first biomarker-based test specifically approved by the FDA to triage women with HPV-positive / Pap cytology-negative co-testing... Read more

March 10, 2020 Lab Top-10 PR/Corporate

Thermo Fisher Scientific Names Paul G. Parker to Head Strategy and Corporate Development

Thermo Fisher Scientific Names Paul G. Parker to Head Strategy and Corporate Development WALTHAM, Mass., March 10, 2020 /PRNewswire/ — Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that Paul G. Parker will join the company, effective April 15, 2020, as senior vice president, strategy and corporate development, which also... Read more

March 9, 2020 Lab Top-10 PAI Top-10 PR/Corporate

PerkinElmer First Quarter 2020 Financial Performance Update

WALTHAM, Mass.–(BUSINESS WIRE)– PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that it expects first quarter 2020 revenue and earnings per share, both on a GAAP and non-GAAP basis, to be below the Company’s previously communicated guidance. Prahlad Singh, president and chief executive officer of PerkinElmer, stated,... Read more

March 5, 2020 PR/Corporate

Christian Henry Appointed Chairman of Pacific Biosciences’ Board of Directors

MENLO PARK, Calif., March 05, 2020 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq:PACB), a leading provider of high-quality sequencing of genomes, transcriptomes and epigenomes, today announced that industry veteran Christian Henry has been appointed to serve as Chairman of its Board of Directors.As part of its annual review of the leadership structure of... Read more

March 5, 2020 Lab Top-10 PR/Corporate

Bruker Receives Notification from Nasdaq Related to Delayed Annual Report on Form 10-K

BILLERICA, Mass.–(BUSINESS WIRE)– Bruker Corporation (Nasdaq: BRKR) today announced that it received a letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that, as a result of Bruker’s delay in filing its Annual Report on Form 10-K for the fiscal year ended December 31, 2019 (the “Form 10-K”), Bruker is... Read more

March 5, 2020 PR/Corporate Product Launch

Xylem appoints two new commercial and segment leaders to executive team

RYE BROOK, N.Y.–(BUSINESS WIRE)– Global water technology company, Xylem (NYSE:XYL), today announced two senior appointments to its executive team. Hayati Yarkadas has been appointed Senior Vice President, and President, Water Infrastructure & Europe Commercial Team. Yarkadas was most recently President of Performance Materials at Trinseo, based in Switzerland. Matthew Pine has been appointed Senior Vice... Read more

March 2, 2020 PR/Corporate

QIAGEN announces 20-F annual report filing for 2019 results

Germantown, Maryland, and Hilden, Germany, March 2, 2020 – QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced today that it has filed its annual report, including its audited consolidated financial statements on Form 20-F, for the year ended December 31, 2019, with the U.S. Securities and Exchange Commission. The document can be accessed on... Read more